RET C609Y

有一些功能性证据表明,这种变异导致ret活性降低(pmid:9230192),细胞增殖和抗凋亡能力增强(pmid:16715139)。广泛报道于家族性和散发性多发性内分泌肿瘤2型髓样甲状腺癌。尽管在gnomad浏览器中对总共约150K等位基因进行了广泛的工作组和外显子覆盖,但从未观察到这种变异。
There is some functional evidence that this variant leads to reduced RET activity (PMID: 9230192) and increased cell proliferation and resistance to apoptosis (PMID: 16715139). It has been widely reported in both familial and sporadic cases of multiple endocrine neoplasia type 2 with medullary thyroid cancers. Despite extensive WGS and Exome coverage for a combined total of ~150k alleles in the GNOMAD browser, this variant has never been observed.

别名

突变位点

Ref. Build: GRCh37   Ensembl Version: 75
Chr.StartStopRef. sVar. Bases
104360907043609070GA
Transcript
ENST00000355710.3

基因序列

NM_020630.4:c.1826G>003eA
NC_000010.10:g.43609070G>003eA
NP_065681.1:p.Cys609Tyr
ENST00000355710.3:c.1826G>003eA